Efficient BLG-Cre mediated gene deletion in the mammary gland - PubMed (original) (raw)

Efficient BLG-Cre mediated gene deletion in the mammary gland

S Selbert et al. Transgenic Res. 1998 Sep.

Abstract

Using the phage P1-derived Cre/loxP recombination system, we have developed a strategy for efficient mammary tissue specific inactivation of floxed genes. Transgenic mice were generated which express Cre DNA-recombinase under the control of the mammary gland specific promoter of the ovine beta-lactoglobulin (BLG) gene. To test the specificity of Cre mediated recombination, we crossed these mice to animals harbouring a floxed DNA ligase I allele. We show that the BLG-Cre construct specifies mammary specific gene deletion, and furthermore that it is temporally regulated, predominantly occurring during lactation. We fully characterised the extent of gene deletion in one line (line 74). In this strain the virgin gland is characterised by low levels (7%) of Cre mediated deletion, whereas 70-80% of cells within the lactating mammary gland have undergone recombination. Immunohistochemistry and indirect in situ PCR were used respectively to demonstrate that both Cre protein and Cre activity were evenly distributed throughout the population of secretory epithelial cells. The level of background recombination in non-mammary tissues was found to be < or = 1.1%, irrespective of mammary gland developmental status. Crossing the transgenic BLG-Cre strain described here to mice harbouring other floxed alleles will facilitate the functional analysis of those genes during differentiation and development of the mammary gland.

PubMed Disclaimer

Similar articles

• Ectopic expression of beta-lactoglobulin/human serum albumin fusion genes in transgenic mice: hormonal regulation and in situ localization.
  Barash I, Faerman A, Ratovitsky T, Puzis R, Nathan M, Hurwitz DR, Shani M. Barash I, et al. Transgenic Res. 1994 May;3(3):141-51. doi: 10.1007/BF01973981. Transgenic Res. 1994. PMID: 8025593
• Cre-mediated gene deletion in the mammary gland.
  Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L, Li M, Furth PA, Hennighausen L. Wagner KU, et al. Nucleic Acids Res. 1997 Nov 1;25(21):4323-30. doi: 10.1093/nar/25.21.4323. Nucleic Acids Res. 1997. PMID: 9336464 Free PMC article.
• The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3.
  Chapman RS, Lourenco P, Tonner E, Flint D, Selbert S, Takeda K, Akira S, Clarke AR, Watson CJ. Chapman RS, et al. Adv Exp Med Biol. 2000;480:129-38. doi: 10.1007/0-306-46832-8_16. Adv Exp Med Biol. 2000. PMID: 10959419 Review.
• Inducible gene targeting in mice using the Cre/lox system.
  Sauer B. Sauer B. Methods. 1998 Apr;14(4):381-92. doi: 10.1006/meth.1998.0593. Methods. 1998. PMID: 9608509 Review.

Cited by

• Intracellular calcium links milk stasis to lysosome-dependent cell death during early mammary gland involution.
  Jeong J, Lee J, Talaia G, Kim W, Song J, Hong J, Yoo K, Gonzalez DG, Athonvarangkul D, Shin J, Dann P, Haberman AM, Kim LK, Ferguson SM, Choi J, Wysolmerski J. Jeong J, et al. Cell Mol Life Sci. 2024 Jan 12;81(1):29. doi: 10.1007/s00018-023-05044-8. Cell Mol Life Sci. 2024. PMID: 38212474 Free PMC article.
• MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer.
  Doha ZO, Wang X, Calistri NL, Eng J, Daniel CJ, Ternes L, Kim EN, Pelz C, Munks M, Betts C, Kwon S, Bucher E, Li X, Waugh T, Tatarova Z, Blumberg D, Ko A, Kirchberger N, Pietenpol JA, Sanders ME, Langer EM, Dai MS, Mills G, Chin K, Chang YH, Coussens LM, Gray JW, Heiser LM, Sears RC. Doha ZO, et al. Nat Commun. 2023 Sep 13;14(1):5665. doi: 10.1038/s41467-023-40841-6. Nat Commun. 2023. PMID: 37704631 Free PMC article.
• Alveolar cells in the mammary gland: lineage commitment and cell death.
  Watson CJ. Watson CJ. Biochem J. 2022 May 13;479(9):995-1006. doi: 10.1042/BCJ20210734. Biochem J. 2022. PMID: 35551601 Free PMC article. Review.
• PTPN2 elicits cell autonomous and non-cell autonomous effects on antitumor immunity in triple-negative breast cancer.
  Goh PK, Wiede F, Zeissig MN, Britt KL, Liang S, Molloy T, Goode N, Xu R, Loi S, Muller M, Humbert PO, McLean C, Tiganis T. Goh PK, et al. Sci Adv. 2022 Feb 25;8(8):eabk3338. doi: 10.1126/sciadv.abk3338. Epub 2022 Feb 23. Sci Adv. 2022. PMID: 35196085 Free PMC article.
• Dual recombinase action in the normal and neoplastic mammary gland epithelium.
  Rädler PD, Vistisen K, Triplett AA, Dennaoui R, Li Y, Shrestha H, Ferraiuolo RM, Thangasamy A, Saur D, Wagner KU. Rädler PD, et al. Sci Rep. 2021 Oct 21;11(1):20775. doi: 10.1038/s41598-021-00231-8. Sci Rep. 2021. PMID: 34675248 Free PMC article.

References

1. 1. Gene. 1992 Oct 21;120(2):135-41 - PubMed
2. 1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
3. 1. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6232-6 - PubMed
4. 1. Nucleic Acids Res. 1997 Mar 15;25(6):1317-8 - PubMed
5. 1. Biochem J. 1992 Aug 15;286 ( Pt 1):31-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Research Materials

  • Jackson Laboratory JAX®Mice Database
  • NCI CPTC Antibody Characterization Program